Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
AUTOR(ES)
Baechler, Emily C.
FONTE
The National Academy of Sciences
RESUMO
Systemic lupus erythematosus (SLE) is a complex, inflammatory autoimmune disease that affects multiple organ systems. We used global gene expression profiling of peripheral blood mononuclear cells to identify distinct patterns of gene expression that distinguish most SLE patients from healthy controls. Strikingly, about half of the patients studied showed dysregulated expression of genes in the IFN pathway. Furthermore, this IFN gene expression “signature” served as a marker for more severe disease involving the kidneys, hematopoetic cells, and/or the central nervous system. These results provide insights into the genetic pathways underlying SLE, and identify a subgroup of patients who may benefit from therapies targeting the IFN pathway.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=151388Documentos Relacionados
- Expression of interferon-inducible genes in RD-114 cells.
- The polyoma virus T antigen interferes with interferon-inducible gene expression
- Activation of the human beta-interferon gene requires an interferon-inducible factor.
- Transcriptional analyses of interferon-inducible mRNAs.
- Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells.